Search results for 538

Spark Violet™ 538 anti-human CD303 (BDCA-2) Antibody, CD303, 201A, BioLegend, 354249

Spark Violet™ 538 anti-human CD303 (BDCA-2) Antibody, CD303, 201A, BioLegend, 354250

Spark Violet™ 538 anti-human CD15 (SSEA-1) Antibody, CD15, HI98, BioLegend, 301927

Clone HI98 has been described to specifically react with 3-fucosyl-N-acetyllactosamine (3-FAL), also called X-hapten, SSEA-1, CD15, or Lewis X. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections5and formalin-fixed paraffin-embedded tissue sections.

Spark Violet™ 538 anti-human CD15 (SSEA-1) Antibody, CD15, HI98, BioLegend, 301928

Clone HI98 has been described to specifically react with 3-fucosyl-N-acetyllactosamine (3-FAL), also called X-hapten, SSEA-1, CD15, or Lewis X. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections5and formalin-fixed paraffin-embedded tissue sections.

Spark Violet™ 538 anti-human HLA-DR Antibody, HLA-DR, L243, BioLegend, 307677

The L243 monoclonal antibody reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. Clone L243 binds a conformational epitope on HLA-DRa which depends on the correct folding of the aß heterodimer.19Additional reported applications (for the relevant formats) include: immunoprecipitation8, Western blotting8,in vitroblocking of mixed lymphocyte reactions9,10, depeletion of MHC class II cells7, immunohistochemical staining of acetone-fixed frozen sections4,5, and spatial biology (IBEX)21,22. For sensitive functional assays, we recommend using the Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 307648, 307665 - 307669).

Spark Violet™ 538 anti-human HLA-DR Antibody, HLA-DR, L243, BioLegend, 307678

The L243 monoclonal antibody reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. Clone L243 binds a conformational epitope on HLA-DRa which depends on the correct folding of the aß heterodimer.19Additional reported applications (for the relevant formats) include: immunoprecipitation8, Western blotting8,in vitroblocking of mixed lymphocyte reactions9,10, depeletion of MHC class II cells7, immunohistochemical staining of acetone-fixed frozen sections4,5, and spatial biology (IBEX)21,22. For sensitive functional assays, we recommend using the Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 307648, 307665 - 307669).

Spark Violet™ 538 anti-human TCR Cβ1 Antibody, TCR Cβ1, JOVI.1, BioLegend, 383513

Clone JOVI.1 can interfere with the binding of clone IP26 on target cells.

Spark Violet™ 538 anti-human TCR Cβ1 Antibody, TCR Cβ1, JOVI.1, BioLegend, 383514

Clone JOVI.1 can interfere with the binding of clone IP26 on target cells.

Spark Violet™ 538 anti-mouse/human CD45R/B220 Antibody, CD45R/B220, RA3-6B2, BioLegend, 103283

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1,in vitroandin vivomodulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Spark Violet™ 538 anti-mouse/human CD45R/B220 Antibody, CD45R/B220, RA3-6B2, BioLegend, 103284

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1,in vitroandin vivomodulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.